Last Updated on November 26, 2021 by The Health Master
Dupilumab (also known as Dupixent) will be available to patients through injections. These injections are given every few weeks, and were shown in clinical trials to reduce the frequency of asthma attacks when combined with standard inhalers.
The criteria for people receiving the treatment and getting access to it are strict, and it is given to those with type 2 inflammation, as well as those who have had at least four severe asthma attacks in the last year.
The news has been welcomed by both Asthma UK and the British Lung Foundation Partnership, but they remain unsure about the clarity of the drug and its recommendation to people suffering with asthma.
According to the charities, 200,000 people in the UK battle with regular asthma attacks and emergency hospital visits.
Dr Samantha Walker, Director of Research & Innovation at Asthma UK and the British Lung Foundation Partnership, said:
“While NICE’s decision to recommend dupilumab is cause for celebration, the sad fact is that four in five people with suspected severe asthma are not being referred to specialists for the treatments that could transform, and even save, their lives.”
“Asthma UK and the British Lung Foundation is calling for NICE to develop new, clear guidelines so healthcare professionals are confident about when to refer patients with possible severe asthma to get the specialist care they so desperately need.”
Professor Ian Pavord, Professor of Respiratory Medicine, Respiratory Medicine Unit and Oxford Respiratory NIHR BRC, Nuffield Department of Medicine, University of Oxford, added:
“Living with severe, uncontrolled asthma results is a constant struggle with shortness of breath and wheezing, making it very hard to lead a normal life. It can be life threatening when medications are unable to keep asthma under control and severe asthma attacks are too often a reality.”
Asthma is a condition that affects over 5 million people in the UK.
CDSCO gives nod to Torrent’s FDC for increased strength of Amlodipine,…
Zydus seeks DCGI nod for chronic Kidney disease drug
USFDA gives final nod to Alembic for Formoterol Fumarate inhalation solution
New research on developing Vaccine for UTI
World’s biggest Vegetarian Capsules plant to come in India
Fake body supplements racket busted, 3 arrested
CDSCO approves this Diabetes Tablet for use against Heart Failure
Govt endorses these suggestions to amend D&C Act and DPCO
2 lakh Pharmacies in India by next year: Biddano
Latest Notifications regarding Pharmaceuticals
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
